pubmed-article:12796022 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12796022 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:12796022 | lifeskim:mentions | umls-concept:C0494165 | lld:lifeskim |
pubmed-article:12796022 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
pubmed-article:12796022 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
pubmed-article:12796022 | lifeskim:mentions | umls-concept:C0071126 | lld:lifeskim |
pubmed-article:12796022 | lifeskim:mentions | umls-concept:C1883256 | lld:lifeskim |
pubmed-article:12796022 | lifeskim:mentions | umls-concept:C1134564 | lld:lifeskim |
pubmed-article:12796022 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:12796022 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:12796022 | pubmed:dateCreated | 2003-6-10 | lld:pubmed |
pubmed-article:12796022 | pubmed:abstractText | A prospective phase II study was performed to determine the feasibility, efficacy and safety of arterial hepatic infusion (HAI) using pirarubicin combined with intravenous chemotherapy. | lld:pubmed |
pubmed-article:12796022 | pubmed:language | eng | lld:pubmed |
pubmed-article:12796022 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12796022 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12796022 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12796022 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12796022 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12796022 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12796022 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12796022 | pubmed:month | Jun | lld:pubmed |
pubmed-article:12796022 | pubmed:issn | 0923-7534 | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:JacobJJ | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:ColinPP | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:SeitzJ FJF | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:BaulieuxJJ | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:RougierPP | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:CouzigouPP | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:MahjoubiMM | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:AdenisAA | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:DouillardJ... | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:DucreuxMM | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:YchouMM | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:MahjoubiRR | lld:pubmed |
pubmed-article:12796022 | pubmed:author | pubmed-author:FallikDD | lld:pubmed |
pubmed-article:12796022 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12796022 | pubmed:volume | 14 | lld:pubmed |
pubmed-article:12796022 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12796022 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12796022 | pubmed:pagination | 856-63 | lld:pubmed |
pubmed-article:12796022 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:meshHeading | pubmed-meshheading:12796022... | lld:pubmed |
pubmed-article:12796022 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12796022 | pubmed:articleTitle | Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer. | lld:pubmed |
pubmed-article:12796022 | pubmed:affiliation | Institut Gustave Roussy, Villejuif, France. | lld:pubmed |
pubmed-article:12796022 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12796022 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:12796022 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:12796022 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:12796022 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |